Keyphrases
Tumor
89%
Tumor-infiltrating Lymphocytes
68%
Interleukin-2
55%
T Cells
52%
Breast Cancer
44%
Her2neu
40%
Cytotoxic T Lymphocytes
38%
Tumor Cells
38%
Adoptive Immunotherapy
35%
Tumor-specific
34%
HLA-A2
33%
Tumor Antigen
32%
Breast Reconstruction
29%
Ovarian Cancer
28%
Local Recurrence
24%
Pancreatic Cancer
21%
CD4+
20%
Radiation Therapy
20%
Lymphokine-activated Killer Cells
20%
Cytotoxicity
19%
Dendritic Cells
19%
CD8+ T Cells
18%
Breast
18%
Syngeneic
17%
Lymphoid Cells
17%
Treg
17%
Recombinant interleukin-2
16%
Human Tumors
16%
Early Breast Cancer
15%
Breast Cancer Patients
15%
Lymphocytes
15%
Tumor-associated Lymphocytes
14%
Mastectomy
14%
Murine Tumors
14%
Derived Peptide
13%
Melanoma
12%
Lysis
12%
Cellular Factors
12%
Surgery Therapy
12%
Cancer Immunotherapy
12%
Prognostic Factors
11%
T Cell Receptor
11%
Pancreatic Adenocarcinoma
11%
Conservative Surgery
11%
Tumor Growth
11%
Solid Phase
11%
Autologous Tumors
11%
Mouse Mammary Tumor
11%
Surgical Training
11%
Cancer Patients
10%
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
94%
Recurrent Disease
44%
Cytotoxic T-Cell
43%
Tumor Cell
30%
Pancreas Cancer
29%
Malignant Neoplasm
29%
Interleukin 2
28%
T Cell
27%
In Vitro
26%
Ovarian Cancer
25%
Specific Tumor
24%
Mastectomy
22%
Tumor Infiltrating Lymphocyte
22%
Radiation Therapy
21%
Lymphocyte
20%
Surgery
20%
Tumor Antigen
19%
Cytotoxicity
18%
Cancer
17%
Adoptive Immunotherapy
16%
Surgeon
16%
Diseases
15%
Melanoma
14%
Quadrantectomy
14%
Immunotherapy
14%
Biopsy Technique
13%
Soft Tissue Sarcoma
13%
Interstitial Brachytherapy
13%
Metastatic Carcinoma
12%
Breast Reconstruction
11%
Cell Line
11%
Drug Megadose
11%
Cancer Cell
10%
Regulatory T Cell
10%
Tumor Vaccine
10%
Ovarian Tumor
10%
Breast Tumor
10%
Prognostic Factor
9%
T Lymphocyte
9%
Prospective Study
9%
Overall Survival
9%
Sentinel Lymph Node Biopsy
9%
Neoadjuvant Chemotherapy
8%
Clinical Trial
8%
Medicine
8%
Connective Tissue Cancer
7%
Primary Tumor
7%
General Surgery
7%
T Lymphocyte Receptor
7%
Immunology and Microbiology
T Cell
69%
Interleukin 2
65%
Tumor-Infiltrating Lymphocytes
58%
Tumor Cell
42%
CD4
32%
Immunotherapy
32%
Cytotoxic T Cell
31%
Peptides
30%
Cytotoxicity
30%
Tumor Antigen
26%
Adoptive Immunotherapy
23%
Dendritic Cell
23%
Tumor-Associated Macrophage
22%
HER2/neu
21%
T-Helper Cell
19%
Cell Line
19%
Regulatory T Cell
19%
Cytotoxic T-Cell
18%
Lymphocyte
18%
Cancer Cell
18%
CD8
18%
Cytokine
18%
CD3 Antigen
17%
Syngenic
17%
Lymphokine Activated Killer Cell
16%
Recombinant Interleukin 2
16%
Pancreas
15%
T Cell Receptor
15%
Innate Lymphoid Cell
13%
Solid
11%
Low Drug Dose
11%
Carcinoma Cell
11%
Tumor Vaccine
10%
Wild Type
10%
Epitope
9%
Cyclophosphamide
9%
Prevalence
9%
Cytokine Production
9%
Immune Response
9%
interferon
9%
CD3 Antibody
8%
Interleukin 4
8%
Lymph Node
8%
Human Leukocyte Antigen
8%
Lymphoid Cell Line
8%
Secretion (Process)
7%
Antigen-Presenting Cell
7%
T Helper Cell
7%
Programmed Cell Death
7%
Melanoma Cell
7%